A Case of Disseminated Multidrug-Resistant Tuberculosis involving the Brain
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
We report a case of a 23-year-old female immigrant from China who was diagnosed with multidrug-resistant tuberculosis affecting her lung and brain, resistant to the standard first-line therapeutics and streptomycin. She was treated with prothionamide, moxifloxacin, cycloserine, and kanamycin. However, her headache and brain lesion worsened. After the brain biopsy, the patient was confirmed with intracranial tuberculoma. Linezolid was added to intensify the treatment regimen, and steroid was added for the possibility of paradoxical response. Kanamycin was discontinued 6 months after initiation of the treatment; she was treated for 18 months with susceptible drugs and completely recovered. To our knowledge, this case is the first multidrug- resistant tuberculosis that disseminated to the brain in Korea.
Abstract
We report a case of a 23-year-old female immigrant from China who was diagnosed with multidrug-resistant tuberculosis affecting her lung and brain, resistant to the standard first-line therapeutics and streptomycin. She was treated with prothionamide, moxifloxacin, cycloserine, and kanamycin. However, her headache and brain lesion worsened. After the brain biopsy, the patient was confirmed with intracranial tuberculoma. Linezolid was added to intensify the treatment regimen, and steroid was added for the possibility of paradoxical response. Kanamycin was discontinued 6 months after initiation of the treatment; she was treated for 18 months with susceptible drugs and completely recovered. To our knowledge, this case is the first multidrug- resistant tuberculosis that disseminated to the brain in Korea.
참고문헌 (19)
- "Korean Guidelines for Tuberculosis" (2011)[URL]
- "Guidelines for the programmatic management of drug-resistant tuberculosis" (2011)[URL]
- "Annual report on the notified tuberculosis in Korea, 2012"[URL]
- Mitchison DA, "Drug resistance in tuberculosis", Eur Respir J, 25, pp.376~379 (2005)
- Lacoma A, "GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples", J Clin Microbiol, 46, pp.3660~3667 (2008)
- "Global tuberculosis report, 2013"[URL]
- "Current situation of MDR-TB and XDR-TB in Korea, 2009"[URL]
- Lee WY, "Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication", J Med Microbiol, 60, pp.1550~1552 (2011)
- Lee M, "Linezolid for treatment of chronic extensively drug-resistant tuberculosis", N Engl J Med, 367, pp.1508~1518 (2012)
- Chang KC, "WHO group 5drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis", Antimicrob Agents Chemother, 57, pp.4097~4104 (2013)
- Ntziora F, "Linezolid for the treatment of patients with central nervous system infection", Ann Pharmacother, 41, pp.296~308 (2007)
- Malacarne P, "Linezolid cerebrospinal fluid concentration in central nervous system infection", J Chemother, 19, pp.90~93 (2007)
- Schecter GF, "Linezolid in the treatment of multidrug-resistant tuberculosis", Clin Infect Dis, 50, pp.49~55 (2010)
- Hawkey CR, "Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis", Clin Infect Dis, 40, pp.1368~1371 (2005)
- Joseph P, "Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India", Indian J Med Res, 133, pp.529~534 (2011)
- Kent SJ, "Tuberculous meningitis: a 30-year review", Clin Infect Dis, 17, pp.987~994 (1993)
- Goble M, "Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin", N Engl J Med, 328, pp.527~532 (1993)
- Vinnard C, "Multidrug resistant tuberculous meningitis in the United States, 1993-2005", J Infect, 63, pp.240~242 (2011)
- Patel VB, "Multidrug-resistant tuberculous meningitis in Kwazulu-Natal, South Africa", Clin Infect Dis, 38, pp.851~856 (2004)